Decomposition Tools for Health Expectancy Wilma Nusselder Department of Public Health Erasmus MC Rotterdam, The Netherlands Task.

Slides:



Advertisements
Similar presentations
Unit of EPIDEMIOLOGY SCIENTIFIC INSTITUTE OF PUBLIC HEALTH HEALTH EXPECTANCY INDICATORS IN BELGIUM 4th Meeting of the Task Force on Health Expectancies.
Advertisements

Healthy Life Years (HLY) at age 65 in the European Union using the SILC 2005 The EHEMU Team
Chronic Disease Prevention and Management Why is this focus area important? Chronic disease such as heart disease, stroke, cancer, diabetes and arthritis.
Evidence based use of Stats SA data for implementation of HIV&AIDS Program Ms Y.Tsibolane FS DoH, HIV and AIDS Program Date: October 2013.
Work package 8 Inequalities in summary measures of population health Prof. Pekka Martikainen & Dr. Netta Mäki Population Research Unit / Faculty of Social.
Progress of Task Force on Health Expectancies (TF-HE) Joint meeting of the Networks of CA and WPL July Jean-Marie Robine Carol Jagger.
Healthy life expectancy in the EU 15 Carol Jagger EHEMU team Europe Blanche XXVI Living Longer but Healthier lives Budapest November 2005.
Project Partners: 計劃夥伴: Funded by: 捐助機構: Gap of Health Care for Midlife Women: Controlling Risk Factors of Stroke as Example Chau Pui Hing CADENZA Project,
A Profile of Chronic Disease in Nevada Tracey Green, MD Nevada State Health Officer January Shaping a Healthy Nevada: Making a Difference in.
What is Epidemiology? The study of the distribution and determinants of diseases and injuries in human populations. Source: Mausner and Kramer, Mausner.
HEALTH EXPECTANCY IN RUSSIAN FEDERATION: GENDER DIFFERENCES AND CROSS-COUNTRY COMPARISONS Ramonov Alexander, post-graduate student, Higher School.
Physical Activity: the best route to population health
Disability free Life Expectancy Carol Jagger University of Leicester EHEMU Team European Population Day: Ageing IUSSP Tours 2005.
Chapter 8 - Focus Chapter : Chronic obstructive pulmonary disease among people aged 55 years and over.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
Estimating social inequalities in Healthy Life Years in Belgium Estimating social inequalities in HLE: Challenges and opportunities 10 February, 2012 Rana.
03/20151 Back to Basics, 2015 POPULATION HEALTH : Vital & Health Statistics Dr. Nicholas Birkett School of Epidemiology, Public Health and Preventive Medicine.
Lecture 3: Measuring the Occurrence of Disease
DISABILITY In INDIA : An Overview Presented by: Ms. Amitpal Kaur.
Health Benefits of Physical Activity
Chronic disease and its impact on disability and the need for LTC Carol Jagger Experts' Seminar on Ageing and Long-Term Care Needs 20 May 2011.
Trends in Disability Trajectories and Subsequent Mortality A study based on the German Socioeconomic Panel for the Periods and with.
03/20131 Back to Basics, 2013 POPULATION HEALTH : Vital & Health Statistics Presented by N. Birkett, MD Epidemiology & Community Medicine.
1 Psychology 320: Psychology of Gender and Sex Differences Lecture 56.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Johan Mackenbach Department of Public Health, Erasmus MC Rotterdam, Netherlands.
Canadian Study of Health and Aging The Incidence and Progression of Dementia 1996 Follow-Up Study.
A HEALTHY LIFE FOR ALL LONGER HEALTHY AND MORE ACTIVE? LESS UNHEALTHY LIFE? Herman Van Oyen Seminarie ‘‘Veel langer leven en actief blijven. Sociale, demografische.
Health expectancy to monitor health: Achievements and challenges ahead in the Netherlands Wilma Nusselder Department of Public Health Erasmus MC Rotterdam,
WORKSHOP AGIR THE HAGUE FEBRUARY RESULTS FOR BELGIUM – WP1 J. MESTDAGH – M. LAMBRECHT Federal Planning Bureau Economic Analysis & Forecasts.
Illinois State University Exercise and Body Composition Relationships of Total and Regional Body Composition to Morbidity and Mortality.
University of Leeds, March 2008 Domenica Rasulo (User Fellow)
Health Care Issues Affecting Business Operations of the Commonwealth June 21,
Presented at The 129th Annual Meeting of the American Public Health Association Atlanta, GA, October 21–25, 2001 Presented by Kristine R. Broglio Thomas.
Comorbidities and Diabetes Care – Impact on Treatment Strategies Dr. Joel Rodriguez-Saldana Multidisciplinary Diabetes Centres Mexico.
“Of MS and Men” Morbidity & Mortality Outcomes Mitchell T. Wallin, MD, MPH MS Clinic Director Department of Veterans Affairs Medical Center Washington,
7 th Task Force on Health Expectancies Meeting Luxembourg, 2 December 2008 Dr. Enrique Loyola Health Intelligence Service Summary measures in public health.
HEALTH EXPECTANCIES IN SPAIN ( ) Juan L. Gutiérrez Fisac Instituto de Información Sanitaria Ministerio de Sanidad y Consumo Spain.
中国农村心血管病防治面临的挑战 Challenges in prevention and control of CVD in Rural China Yangfeng Wu, MD, PhD The George Institute for Global Health at Peking University.
The Scottish Health Survey: multiple risk factors in adults aged 16+ years Catherine Bromley, ScotCen Faculty of Public Health Conference Aviemore 10 November.
The experience of Denmark with global disability questions in surveys Ola Ekholm & Henrik Brønnum-Hansen, National Institute of Public Health, University.
WP 2:Future disease patterns and their implications for disability in later life C. Jagger, R. Matthews, J. Lindesay Leicester Nuffield Research Unit.
Health expectancy in Denmark 3 rd Meeting of the Task Force on Health Expectancies Luxembourg, 12 December 2006 Henrik Brønnum-Hansen Secular trends Social.
Scientific Institute of Public Health Unit of Epidemiology REVES HEALTH EXPECTANCIES IN BELGIUM RESULTS FROM THE 2001 CENSUS H. Van Oyen (ISP) S.
Office for National Statistics University of Leeds, March 2007 Domenica Rasulo.
The EHLEIS project of the European health expectancy monitoring unit 2oo7-2o1o European health expectancy monitoring unit.
INTRODUCTION TO COMMUNITY DENTISTRY 2 BY.DR.HINA ADNAN DNT 362.
Meeting WP indicators May 31 - June 1, 2007; focus on development of the ECHIM shortlist Pieter Kramers Task Force on Major and Chronic Diseases Luxembourg.
03/20121 Back to Basics, 2012 POPULATION HEALTH : Vital & Health Statistics Presented by N. Birkett, MD Epidemiology & Community Medicine.
Progress of Task Force on Health Expectancies (TF-HE) Joint meeting of the Networks of CA and WPL Jan Carol Jagger Jean-Marie Robine.
The Aging Process from a Quality of Life Perspective Ingalill Rahm Hallberg, Professor, Director of the Swedish Institute for Health Sciences Assistant.
HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.
Outline the findings and recommendations of the James Report. LESSON STARTER.
Widening of Socioeconomic Disparities in U.S. Mortality from Major Cancers Ahmedin Jemal, PhD Elizabeth Ward, PhD June 10, 2008 Kinsey T, Jemal A, Liff.
SOCIOECONOMIC INEQUALITIES IN HEALTH a view from Europe Johan Mackenbach Department of Public Health Erasmus MC Rotterdam, Netherlands.
Diabetes: 0–44 years Ranked comorbidity combinations Source: ABS Australian Health Survey 2011–12 (National Health Survey component) For people aged 0–44,
Hannah Weir, PhD Chunyu Li, MD, PhD Division of Cancer Prevention and Control Centers for Disease Control and Prevention, USA North American Association.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Exploring the potential of the ESEC for describing class differences in health in European populations Anton Kunst on behalf of the Dutch team January.
Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.
Surrey Downs CCG Health Profile Health Profile Summary Population – current, projected & specific groups Wider determinants Health behaviours Disease.
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Office for National Statistics
Association between GDP and old-age mortality in seven European countries, A life-course perspective F.Janssen, A.E.Kunst, J.P.Mackenbach Department.
HEALTH EXPECTANCIES IN BELGIUM RESULTS FROM THE 2001 CENSUS
A “Scottish effect” for health?
Disability Free Life Expectancy (2011) in Goa: Some Implications For Health Policy Dr. M.S. Kulkarni Associate Professor in Statistics & Demography Goa.
Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

Decomposition Tools for Health Expectancy Wilma Nusselder Department of Public Health Erasmus MC Rotterdam, The Netherlands Task Force on Health Expectancy, Luxembourg, June 8, 2006

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to 10 years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to 10 years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible responsible for this difference? Step 3: to explain differences in HE between for this difference? Which causes of death and disability are MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in H between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools

Health expectancy (HE) in the EU Step 1: HE to describe population health: EHEMU database New questions: Is this low or high relative to other MS? Is this low or high relative to other sex/subpopulation? Is this low or high as compared to five years ago? Step 2: to compare HE between MS, within MS, over time EHEMU database New questions: Is difference due to higher mortality or higher disability? Which age groups are responsible for this difference? Which causes of death and disability are responsible for this difference? Step 3: to explain differences in HE between MS, within MS, over time Decomposition tools Contribution of mortality vs. disability, age groups and causes to HE differences

Decomposition tools Decomposition (or partition techniques) are widely used in mortality research to decompose differences in life expectancy (LE) By age: additive contribution of age groups By cause: additive contribution of causes of death For HE derived with the Sullivan method decomposition tools have recently been developed (Nusselder & Looman, 2004; ******) By type: additive contribution of mortality and disability By age: additive contribution of age groups By cause: additive contribution of causes of death and causes of disability

Decomposition tools Decomposition (or partition techniques) are widely used in mortality research to decompose differences in life expectancy (LE) -By age: additive contribution of age groups -By cause: additive contribution of causes of death Decomposition tools have recently been developed (Nusselder & Looman, 2004; Andreev et al, 2003) to decompose differences in health expectancy (HE) -By type: additive contribution of mortality and disability -By age: additive contribution of age groups -By cause: additive contribution of causes of death and causes of disability

Date needed for decomposition of HE Decomposition by kind of effect & age: Mortality rates by age and sex Disability prevalence by age and sex Decomposition by cause: Mortality rates by age, sex and cause of death Disability prevalence by age, sex and cause of disability = Not generally available: can be derived from individual-level survey data on age, sex, disability and chronic diseases

Two illustrations 1.Gender gap in years with disability in the Netherlands 2.SES disparities in DFLE in Belgium 3.Other possible applications: 1.Differences in HE over time 2.Differences in HE between MS

1. Decomposition of gender gap in HE (a) Why is number of years with disability higher among women?

1. Decomposition of gender gap in HE (b) Source : Nusselder & Looman, 2004.

1. Decomposition of gender gap in HE (c) Difference in years with disability: men 8.4 vs. women 14.8 yrs Source : Nusselder & Looman, 2004.

2. Decomposition of SES disparity in DFLE (a) Source : Nusselder et al, 2005.

2.Decomposition of SES disparity in DFLE (b) Source : Nusselder et al, 2005.

2. Decomposition of SES disparity by cause, men Mort.Disab.Total Total difference in DFLE Due to Cancer Heartdisease/stroke asthma/COPD Diabetes mellitus Back complaints Arthritis Other diseases Background Source : Nusselder et al, 2005.

2. Decomposition of SES disparity by cause, men Source : Nusselder et al, 2005.

2. Decomposition of SES disparity by cause, women Source : Nusselder et al, 2005.

2. Decomposition of SES disparity by cause, women Source : Nusselder et al, 2005.

Added value of decomposition tools Provides more insight into differences in health Mortality vs. disability Mortality -> which age -> which cause of death Disability -> which age -> which chronic disease * prevalence of disease * disabling impact of disease Provides parsimonious summary of contribution of specific diseases to health differences Takes into account that contribution of disease depends on huge amount of factors (e.g., differences in prevalence, disabling impact, age distribution, mortality from the disease, age distribution of mortality from the disease, mortality from other causes)

Conclusion Decomposition of HE is feasible Decomposition of HE is useful to explain differences in HE between MS, within MS and over time More work is needed to make tool widely applicable: Publicly available program to decompose differences in HE Publicly available program to obtain cause-specific disability information

Thank you for your attention